Healthy volunteers help scientists track drug's journey through the body
NCT ID NCT07494175
First seen Mar 28, 2026 · Last updated May 08, 2026 · Updated 5 times
Summary
This early-stage study aims to understand how a single dose of a radioactive drug called HRS-9190 is absorbed, broken down, and removed from the body. Six healthy men aged 18 to 45 will receive the drug by injection. The study does not treat any disease; it simply gathers information to guide future research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT MALE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
First Affiliated Hospital of Shandong First Medical University (Shandong Provincial Qianfoshan Hospital)
Jinan, Shandong, 250014, China
Conditions
Explore the condition pages connected to this study.